Today @CognifiSense welcomes Amanda Way as CEO.
We are so excited to welcome Amanda to lead the company as we launch our first commercial product. VRNT (Virtual Reality Neuropsychological Therapy) is a patented, FDA cleared therapy for chronic low back pain.
VR THERAPY FOR CHRONIC LOW BACK PAIN GETS FDA CLEARANCE
@CognifiSense announced today that its proprietary VR therapy for chronic pain received @US_FDA clearance. With deep gratitude we thank all the many people who contributed to this achievement.
https://t.co/9tz9sTUth3
Thank you to my co-authors Maureen Simmonds and Kyle Lepage for a successful pilot study on the use of Virtual Reality to measure pain. Just published in the ANNUAL REVIEW OF CYBERTHERAPY AND TELEMEDICINE 2019 (https://t.co/5991t6c0fU — page 137). #VirtualReality#pain
CognifiSense is honored to be one of the selected awardees! #nihHEALinitiative@nih@ninr@CognifiSense
NIH funds $945 million in research to tackle the national opioid crisis through NIH HEAL Initiative https://t.co/WlWNTp66sj
@LynnRWebsterMD on VR for pain management and especially @CognifiSense and our development stage chronic pain therapy. Great talk, Lynn! https://t.co/hGEkIer2UG
Humbled to be part of an effort to find new solutions to pain measurement. @CognifiSense#VR#ChronicPain#PainMeasurement
Purdue Pharma LP Supports Pain Assessment Research https://t.co/3LhOG3m6sr
Amazing ingenuity at the #xMED innovation lab, like this startup applying VR to help with chronic and phantom pain paralysis and amputees https://t.co/hFb13WOmEA